Emergent BioSolutions to Participate in Investor Conferences
June 02 2022 - 8:20AM
Emergent BioSolutions Inc. (NYSE: EBS) announced today that members
of the company’s executive management team will participate in the
following investor conferences:
- Benchmark Healthcare House Call Virtual 1X1
ConferenceJune 2, 2022
- NYSE Healthcare & Technology Virtual Investor
Access DayJune 8, 2022
- East Coast IDEAS ConferenceJune 22,
2022Pre-recorded presentation will be accessible beginning at 6:00
am EThttps://wsw.com/webcast/threepa37/ebs/
For conferences where a presentation is planned, the company’s
webcast presentation may include a discussion of the company's
recent business developments as well as its financial results and
guidance. The webcasts will be available both live, if possible,
and by replay, and will be accessible from the Emergent
website.
About Emergent BioSolutionsAt Emergent, our
mission is to protect and enhance life. For over 20 years, we’ve
been at work defending people from things we hope will never
happen—so we are prepared, just in case they ever do. We provide
solutions for complex and urgent public health threats through a
portfolio of vaccines and therapeutics that we develop and
manufacture for governments and consumers. We also offer a range of
integrated contract development and manufacturing services for
pharmaceutical and biotechnology customers. To learn more about how
we plan to protect or enhance 1 billion lives by 2030, visit our
website and follow us on LinkedIn, Twitter, and Instagram.
Investor Contact:Robert G.
BurrowsVice President, Investor
Relations240-631-3280burrowsr@ebsi.com
Media Contact:Matt HartwigSenior
Director, Media Relationsmediarelations@ebsi.com
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Aug 2023 to Aug 2024